SLDB EBITDA Growth
Solid Biosciences Inc · EBITDA Growth
SLDB EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-35.08%period ending
SLDB TTM EBITDA YoY % (-65.42% → -35.08%)
Year-over-year change
High-resolution chart · PNG
SLDB ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -35.0772% | |
| -38.9306% | |
| -41.5572% | |
| -65.2899% | |
| -72.7791% | |
| -55.3011% | |
| -30.9423% | |
| 1.3331% | |
| 12.8568% | |
| 12.2049% | |
| 3.1259% | |
| -18.4165% | |
| -21.9541% | |
| -29.2143% | |
| -38.8789% | |
| -19.0311% | |
| -10.2694% | |
| -3.8247% | |
| 16.1655% | |
| 23.1144% | |
| 26.3514% | |
| 32.4132% | |
| 29.1466% | |
| 12.5025% | |
| -5.6761% | |
| -25.6537% | |
| -57.1673% | |
| -59.1491% | |
| -55.3504% | |
| -57.0267% | |
| -36.2293% | |
| -39.4452% | |
| -65.4154% |